Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction

Exclusion Criteria

• •Subjects with a known low ejection fraction of less than 40% or any previous history of heart failure.
• •Subjects treated with eplerenone or other aldosterone antagonists within the past 1 month.
• •The subject has uncontrolled hypotension (SBP\<90mmHg).
• •Subjects with eGFR ≤30ml/min (based on admission serum creatinine and the MDRD formula) or serum creatinine ≥220µmol/L.